| Dr Ziad Richard Sawan I, MD | |
|
16003 Tuscola Rd, Suite F, Apple Valley, CA 92307-1319 | |
| (760) 242-8221 | |
| (760) 242-8859 |
| Full Name | Dr Ziad Richard Sawan I |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 40 Years |
| Location | 16003 Tuscola Rd, Apple Valley, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912958786 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | G55163 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vvipa Medical Group Inc | 5092185546 | 12 |
News Archive
Study results show that the growth rate of female lambs given feed drenched with Agave extract or Quillaja saponaria – both of which contain saponins – increased over 2 months, indicating they may act as natural defaunating agents.
At the U.N. High Level Meeting on AIDS, PEPFAR "will join with UNAIDS and other partners in releasing a new global action plan for the prevention of mother-to-child-transmission of HIV/AIDS. The U.S. will also place additional resources into helping move towards eliminating pediatric HIV," according to a State Department press release.
Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin in combination with chemotherapy for the treatment of newly diagnosed systemic anaplastic large cell lymphoma patients.
› Verified 6 days ago
| Entity Name | Sawan Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336471242 PECOS PAC ID: 2668408915 Enrollment ID: O20050708000869 |
News Archive
Study results show that the growth rate of female lambs given feed drenched with Agave extract or Quillaja saponaria – both of which contain saponins – increased over 2 months, indicating they may act as natural defaunating agents.
At the U.N. High Level Meeting on AIDS, PEPFAR "will join with UNAIDS and other partners in releasing a new global action plan for the prevention of mother-to-child-transmission of HIV/AIDS. The U.S. will also place additional resources into helping move towards eliminating pediatric HIV," according to a State Department press release.
Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin in combination with chemotherapy for the treatment of newly diagnosed systemic anaplastic large cell lymphoma patients.
› Verified 6 days ago
| Entity Name | Vvipa Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295126001 PECOS PAC ID: 5092185546 Enrollment ID: O20221228001648 |
News Archive
Study results show that the growth rate of female lambs given feed drenched with Agave extract or Quillaja saponaria – both of which contain saponins – increased over 2 months, indicating they may act as natural defaunating agents.
At the U.N. High Level Meeting on AIDS, PEPFAR "will join with UNAIDS and other partners in releasing a new global action plan for the prevention of mother-to-child-transmission of HIV/AIDS. The U.S. will also place additional resources into helping move towards eliminating pediatric HIV," according to a State Department press release.
Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin in combination with chemotherapy for the treatment of newly diagnosed systemic anaplastic large cell lymphoma patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ziad Richard Sawan I, MD 16003 Tuscola Rd, Suite H, Apple Valley, CA 92307-1319 Ph: (760) 242-8400 | Dr Ziad Richard Sawan I, MD 16003 Tuscola Rd, Suite F, Apple Valley, CA 92307-1319 Ph: (760) 242-8221 |
News Archive
Study results show that the growth rate of female lambs given feed drenched with Agave extract or Quillaja saponaria – both of which contain saponins – increased over 2 months, indicating they may act as natural defaunating agents.
At the U.N. High Level Meeting on AIDS, PEPFAR "will join with UNAIDS and other partners in releasing a new global action plan for the prevention of mother-to-child-transmission of HIV/AIDS. The U.S. will also place additional resources into helping move towards eliminating pediatric HIV," according to a State Department press release.
Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin in combination with chemotherapy for the treatment of newly diagnosed systemic anaplastic large cell lymphoma patients.
› Verified 6 days ago
Dr. James A Hartleroad, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 16000 Apple Valley Rd Ste C3, Apple Valley, CA 92307 Phone: 760-242-8900 Fax: 760-242-8994 | |
Nancy Ann Jones, D..O. General Practice Medicare: Medicare Enrolled Practice Location: 18660 Us Highway 18, Apple Valley, CA 92307 Phone: 760-946-2112 | |
Hannibal Edwards, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 19814 Tomahawk Rd, Apple Valley, CA 92307 Phone: 760-242-1903 |